392 related articles for article (PubMed ID: 31438626)
1. Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment.
Brown NF; Marshall JF
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31438626
[TBL] [Abstract][Full Text] [Related]
2. The role of integrins in TGFβ activation in the tumour stroma.
Khan Z; Marshall JF
Cell Tissue Res; 2016 Sep; 365(3):657-73. PubMed ID: 27515461
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β in tumour development.
Trelford CB; Dagnino L; Di Guglielmo GM
Front Mol Biosci; 2022; 9():991612. PubMed ID: 36267157
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation.
de Iongh RU; Wederell E; Lovicu FJ; McAvoy JW
Cells Tissues Organs; 2005; 179(1-2):43-55. PubMed ID: 15942192
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts.
Sheppard D
Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S21-3. PubMed ID: 25830829
[TBL] [Abstract][Full Text] [Related]
6. TGFβ and the Tumor Microenvironment in Colorectal Cancer.
Waldner MJ; Neurath MF
Cells; 2023 Apr; 12(8):. PubMed ID: 37190048
[TBL] [Abstract][Full Text] [Related]
7. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
[TBL] [Abstract][Full Text] [Related]
8. TGFβ Signaling in the Pancreatic Tumor Microenvironment.
Principe DR; Timbers KE; Atia LG; Koch RM; Rana A
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680235
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts.
Peng C; Zou X; Xia W; Gao H; Li Z; Liu N; Xu Z; Gao C; He Z; Niu W; Fang R; Biswas S; Agrez M; Zhi X; Niu J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355650
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of TGFβ on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report.
Koczorowska MM; Friedemann C; Geiger K; Follo M; Biniossek ML; Schilling O
Cell Oncol (Dordr); 2017 Dec; 40(6):639-650. PubMed ID: 28808957
[TBL] [Abstract][Full Text] [Related]
11. Overcoming TGFβ-mediated immune evasion in cancer.
Tauriello DVF; Sancho E; Batlle E
Nat Rev Cancer; 2022 Jan; 22(1):25-44. PubMed ID: 34671117
[TBL] [Abstract][Full Text] [Related]
12. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
[TBL] [Abstract][Full Text] [Related]
13. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
14. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Bierie B; Moses HL
Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
[TBL] [Abstract][Full Text] [Related]
15. TGFβ biology in cancer progression and immunotherapy.
Derynck R; Turley SJ; Akhurst RJ
Nat Rev Clin Oncol; 2021 Jan; 18(1):9-34. PubMed ID: 32710082
[TBL] [Abstract][Full Text] [Related]
16. The TGFBeta pathway as a therapeutic target in cancer.
Seoane J
Clin Transl Oncol; 2008 Jan; 10(1):14-9. PubMed ID: 18208788
[TBL] [Abstract][Full Text] [Related]
17. TGFβ: Signaling Blockade for Cancer Immunotherapy.
Chen SY; Mamai O; Akhurst RJ
Annu Rev Cancer Biol; 2022; 6(1):123-146. PubMed ID: 36382146
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities.
Freeman P; Mielgo A
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967079
[TBL] [Abstract][Full Text] [Related]
19. Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment.
Kapoor SS; Zaiss DMW
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052732
[TBL] [Abstract][Full Text] [Related]
20. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
